受强制性开放获取政策约束的文章 - Henrik Jespersen了解详情
无法在其他位置公开访问的文章：1 篇
HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice
EMV Forsberg, MF Lindberg, H Jespersen, S Alsén, RO Bagge, M Donia, ...
Cancer Research 79 (5), 899-904, 2019
强制性开放获取政策： Knut and Alice Wallenberg Foundation
可在其他位置公开访问的文章：14 篇
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
H Jespersen, MF Lindberg, M Donia, EMV Söderberg, R Andersen, ...
Nature communications 8 (1), 707, 2017
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, ...
Nature communications 12 (1), 5155, 2021
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council, Vinnova, Sweden
Molecular profiling of driver events in metastatic uveal melanoma
J Karlsson, LM Nilsson, S Mitra, S Alsén, GV Shelke, VR Sah, ...
Nature communications 11 (1), 1894, 2020
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
BO Einarsdottir, RO Bagge, J Bhadury, H Jespersen, J Mattsson, ...
Oncotarget 5 (20), 9609, 2014
强制性开放获取政策： Swedish Research Council
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
H Jespersen, R Olofsson Bagge, G Ullenhag, A Carneiro, H Helgadottir, ...
BMC cancer 19, 1-7, 2019
强制性开放获取政策： Knut and Alice Wallenberg Foundation
Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models
L Ny, LY Rizzo, V Belgrano, J Karlsson, H Jespersen, L Carstam, ...
Annals of Oncology 31 (2), 266-273, 2020
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
BO Einarsdottir, J Karlsson, EMV Söderberg, MF Lindberg, ...
Cell Death & Disease 9 (8), 810, 2018
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma
VR Sah, J Karlsson, H Jespersen, MF Lindberg, LM Nilsson, L Ny, ...
Melanoma Research 32 (4), 241-248, 2022
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis
S Bjursten, A Pandita, Z Zhao, C Fröjd, L Ny, C Jensen, T Ullerstam, ...
Journal for Immunotherapy of Cancer 9 (7), 2021
强制性开放获取政策： UK Medical Research Council
Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primary
RO Bagge, A Demir, J Karlsson, B Alaei-Mahabadi, BO Einarsdottir, ...
JCO precision oncology 2, 1-25, 2018
强制性开放获取政策： Knut and Alice Wallenberg Foundation
Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial: study protocol for a randomized controlled trial
CJ Holmberg, D Katsarelias, H Jespersen, A Carneiro, NO Elander, ...
Acta Oncologica 60 (1), 52-55, 2021
强制性开放获取政策： Knut and Alice Wallenberg Foundation
Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma
J Karlsson, LM Nilsson, EMV Forsberg, S Mitra, S Alsén, G Shelke, ...
bioRxiv, 742023, 2019
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
Chemokine analysis in patients with metastatic uveal melanoma suggests a role for CCL21 signaling in combined epigenetic therapy and checkpoint immunotherapy
VR Sah, H Jespersen, J Karlsson, LM Nilsson, M Bergqvist, I Johansson, ...
Cancer Research Communications 3 (5), 884-895, 2023
强制性开放获取政策： Swedish Research Council, Vinnova, Sweden
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in uveal melanoma
VR Sah, H Jespersen, J Karlsson, MF Lindberg, LM Nilsson, L Ny, ...
bioRxiv, 2021.02. 04.429575, 2021
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council
出版信息和资助信息由计算机程序自动确定